Zoetis Net Profit Margin 2011-2021 | ZTS

Current and historical net profit margin for Zoetis (ZTS) from 2011 to 2021. Net profit margin can be defined as net Income as a portion of total sales revenue. Zoetis net profit margin for the three months ending June 30, 2021 was .
Zoetis Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2021-06-30 $7.41B $1.91B 25.76%
2021-03-31 $7.01B $1.77B 25.30%
2020-12-31 $6.68B $1.64B 24.54%
2020-09-30 $6.54B $1.66B 25.42%
2020-06-30 $6.34B $1.62B 25.50%
2020-03-31 $6.34B $1.61B 25.41%
2019-12-31 $6.26B $1.50B 23.96%
2019-09-30 $6.15B $1.46B 23.76%
2019-06-30 $6.05B $1.38B 22.74%
2019-03-31 $5.91B $1.39B 23.47%
2018-12-31 $5.83B $1.43B 24.52%
2018-09-30 $5.72B $1.16B 20.35%
2018-06-30 $5.59B $1.12B 19.95%
2018-03-31 $5.44B $0.98B 17.97%
2017-12-31 $5.31B $0.86B 16.28%
2017-09-30 $5.12B $0.94B 18.29%
2017-06-30 $5.02B $0.88B 17.50%
2017-03-31 $4.96B $0.86B 17.25%
2016-12-31 $4.89B $0.82B 16.80%
2016-09-30 $4.89B $0.69B 14.10%
2016-06-30 $4.86B $0.64B 13.15%
2016-03-31 $4.83B $0.38B 7.83%
2015-12-31 $4.77B $0.34B 7.11%
2015-09-30 $4.81B $0.44B 9.21%
2015-06-30 $4.81B $0.42B 8.74%
2015-03-31 $4.79B $0.59B 12.38%
2014-12-31 $4.79B $0.58B 12.18%
2014-09-30 $4.72B $0.56B 11.91%
2014-06-30 $4.61B $0.53B 11.43%
2014-03-31 $4.57B $0.52B 11.36%
2013-12-31 $4.56B $0.50B 11.05%
2013-09-30 $4.48B $0.39B 8.68%
2013-06-30 $4.40B $0.42B 9.55%
2013-03-31 $4.38B $0.47B 10.62%
2012-12-31 $4.34B $0.44B 10.06%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $95.841B $6.675B
Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $44.620B 7.23
Catalent (CTLT) United States $21.992B 46.49
Stevanato Group S.p.A (STVN) Italy $7.170B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.421B 16.20
USANA Health Sciences (USNA) United States $1.983B 14.94
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.700B 8.55
Rafael Holdings (RFL) United States $0.541B 0.00
Lannett Co Inc (LCI) United States $0.107B 0.00